Sort   by:  
 Page size 
Unknown5-Aminopyrazole-4-Carboxamide-Based Compounds Prevent the Growth of Cryptosporidium parvum.
Not available
S-EPMC5527629 | biostudies-literature
UnknownEmergence and phenotypic characterization of the global SARS-CoV-2 C.1.2 lineage.
Not available
S-EPMC8993834 | biostudies-literature
UnknownDevelopment of 5-Aminopyrazole-4-carboxamide-based Bumped-Kinase Inhibitors for Cryptosporidiosis Therapy.
Not available
S-EPMC6559944 | biostudies-literature
Unknown7 H-Pyrrolo[2,3- d]pyrimidin-4-amine-Based Inhibitors of Calcium-Dependent Protein Kinase 1 Have Distinct Inhibitory and Oral Pharmacokinetic Characteristics Compared with 1 H-Pyrazolo[3,4- d]pyrimidin-4-amine-Based Inhibitors.
Not available
S-EPMC6777988 | biostudies-literature
UnknownPotent and selective inhibitors of CDPK1 from T. gondii and C. parvum based on a 5-aminopyrazole-4-carboxamide scaffold.
Not available
S-EPMC3908674 | biostudies-literature
UnknownNovel Bumped Kinase Inhibitors Are Safe and Effective Therapeutics in the Calf Clinical Model for Cryptosporidiosis.
Not available
S-EPMC5142098 | biostudies-literature
UnknownPyridopyrimidinones as a new chemotype of calcium dependent protein kinase 1 (CDPK1) inhibitors for Cryptosporidium.
Not available
S-EPMC11629397 | biostudies-literature
UnknownComparative assessment of the effects of bumped kinase inhibitors on early zebrafish embryo development and pregnancy in mice.
Not available
S-EPMC8582287 | biostudies-literature
UnknownExamination of ELISA against PCR for assessing treatment efficacy against Cryptosporidium in a clinical trial context.
Not available
S-EPMC10490871 | biostudies-literature
UnknownAnti-Cryptosporidium efficacy of BKI-1708, an inhibitor of Cryptosporidium calcium-dependent protein kinase 1.
Not available
S-EPMC12310023 | biostudies-literature
Sort   by:  
 Page size